Brain Neoplasm
📧 Sign up to get email alerts when something new happens for Brain Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: 3T MRI Biomarkers of Glioma Treatment Response [EARLY_Phase 1]
An early-phase 1 trial evaluating 3T MRI biomarkers for glioma treatment response, sponsored by Vanderbilt-Ingram Cancer Center, has been te…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy in combination with sargramostim (GM-CSF) for malignant glioma, including several glioma…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors [Phase 2]
Phase 2 trial evaluating bevacizumab with or without trebananib for recurrent brain tumors has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 1, Phase 2]
Clinical trial update for Temsirolimus and Perifosine in recurrent or progressive malignant glioma (Phase 1/2) with completed status and pos…
-
CLINICAL_TRIALS research · 2016-01-20Clinical Trial Update: Assessing the Patient Experience in Cancer Care
A completed Mayo Clinic clinical trial update examining patient experience in cancer care across multiple cancer types; the study status is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-10-23Clinical Trial Update: Assistance in Neurosurgery (ExtempoRMN)
Clinical trial update for ExtempoRMN in neurosurgery at University Hospital, Strasbourg, studying glioma/primary brain tumor; the current st…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor [Phase 1, Phase 2]
Phase 1/2 trial evaluating imatinib mesylate for recurrent brain tumors completed, with results posted in 2014.
-
CLINICAL_TRIALS research · 2014-05-13Clinical Trial Update: Subclavian Vein catheterization_Seldinger Vs Modified Seldinger [NA]
Clinical trial update comparing subclavian vein catheterization methods (Seldinger vs Modified Seldinger); brain-related conditions are list…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [Phase 1]
Phase 1 study evaluating the combination of motexafin gadolinium and temozolomide in malignant gliomas has completed.